Australia markets closed

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
87.38-1.47 (-1.65%)
At close: 04:00PM EDT
87.38 0.00 (0.00%)
After hours: 04:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.44B
Enterprise value 5.07B
Trailing P/E 38.16
Forward P/E 19.01
PEG ratio (5-yr expected) 1.58
Price/sales (ttm)3.43
Price/book (mrq)4.63
Enterprise value/revenue 3.87
Enterprise value/EBITDA 19.35

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-0.86%
S&P500 52-week change 324.52%
52-week high 397.97
52-week low 370.74
50-day moving average 388.81
200-day moving average 385.03

Share statistics

Avg vol (3-month) 3541.45k
Avg vol (10-day) 3861.43k
Shares outstanding 550.84M
Implied shares outstanding 650.84M
Float 850.34M
% held by insiders 10.77%
% held by institutions 1101.89%
Shares short (15 May 2024) 42.5M
Short ratio (15 May 2024) 45.11
Short % of float (15 May 2024) 47.49%
Short % of shares outstanding (15 May 2024) 44.93%
Shares short (prior month 15 Apr 2024) 42.24M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2024
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 8.98%
Operating margin (ttm)15.57%

Management effectiveness

Return on assets (ttm)6.26%
Return on equity (ttm)13.22%

Income statement

Revenue (ttm)1.31B
Revenue per share (ttm)25.82
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)N/A
EBITDA 295.45M
Net income avi to common (ttm)117.56M
Diluted EPS (ttm)2.29
Quarterly earnings growth (yoy)-30.70%

Balance sheet

Total cash (mrq)180.47M
Total cash per share (mrq)3.55
Total debt (mrq)873.88M
Total debt/equity (mrq)91.03%
Current ratio (mrq)2.56
Book value per share (mrq)18.90

Cash flow statement

Operating cash flow (ttm)181.75M
Levered free cash flow (ttm)124.38M